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112 Could contaminated industrial products be the source
of acquisition of Burkholderia cepacia complex in cystic
ﬁbrosis (CF) patients?
L.I. Galanternik1, J. Degrossi2, M. Vazquez1, S. Teves2, A. Teper3. 1Hospital
de Nin˜os Ricardo Guitie´rrez, Microbiology, Buenos Aires, Argentina; 2School
of Pharmacy and Biochemistry, Buenos Aires University, Hygiene Department,
Buenos Aires, Argentina; 3Hospital de Nin˜os Ricardo Gutie´rrez, Respiratory
Center, Buenos Aires, Argentina
Due to the difﬁculty in the treatment of Bcc infections, the main goal is to prevent
acquisition of these bacteria. Cross infection through contact with infected patients
is the most common source of Bcc transmission among CF patients. However, some
other sources such as natural environments, hospital and industrial products have
also been studied.
Objective: To compare Bcc strains isolated from CF patients and industrial sources.
Methods: Since 2007, 28 out of 174 CF patients assisted at our Center harbored, at
least once, Bcc in their sputum. Bcc presence in contaminated industrial products
has been analyzed at the School of Pharmacy and Biochemistry since 1998.
Bcc strains (n = 16) isolated from CF patients were genetically compared with 25
strains isolated from contaminated products and industrial settings using recA gene
sequence analysis and Random Ampliﬁcation of Polymorphic DNA (RAPD).
Burkholderia cepacia, B. cenocepacia, B. vietnamiensis and B. contaminans were
recovered from both sources, the last one being the most frequent species isolated
in Argentina.
Very closely related B. cepacia and B. contaminans strains were isolated from both
sources.
Burkholderia cepacia isolated from a cosmetic cream proved to be genetically
similar to one CF patient’s strain. B. contaminans isolated from an antiseptic was
similar to 2 patients’ strains and one from puriﬁed water from the pharmaceutical
industry proved to be similar to 2 other patients’ strains.
Conclusions: These results reinforce the fact that contaminated products from
industrial sources should be considered a potential source of Bcc reservoir for
CF patients. The presence of Bcc in industrial products should be considered to be
under control.
113 A novel diagnostic PCR for identiﬁcation of highly transmissible
Burkholderia cenocepacia ST32 infection
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Burkholderia cepacia complex (Bcc) bacteria cause serious lung infections in
patients with cystic ﬁbrosis (CF). Furthermore, some Bcc infections can be spread
within a CF community as was the case in the Prague CF centre where a single strain
Burkholderia cenocepacia ST32 infected 30% of patients during 1990s-mid2000s.
For Bcc species and strain identiﬁcation, methods of choice are a culture and recA-
PCR followed by Multilocus Sequence Typing (MLST). The aim of this work was to
develop a strain speciﬁc PCR that enables simple, rapid and inexpensive detection
of ST32, the most prevalent Bcc strain in the Prague CF centre.
Genomic subtractive hybridization between closely related strains B. cenocepacia
ST28 and ST32 was employed to isolate unique sequences, suitable for designing
an ST32-speciﬁc PCR. Its speciﬁcity and sensitivity was evaluated on 57 non-ST32
strains belonging to 17 various Bcc species and 50 clinical isolates previously
assigned by MLST as to be ST32.
A-325 bp long DNA sequence encoding a hypothetical protein was selected as a
target for ST32-speciﬁc PCR. All tested ST32 isolates were PCR positive and all but
one non-ST32 strains provided negative results. Cross-reactivity was detected for
B. cenocepacia ST33 that actually differs from ST32 by only one single nucleotide
polymorphism present within 2773 bp (a length of concatenated sequence for MLST
analysis).
The novel PCR has been proven to be a reliable and useful technique for detection
of epidemic strain B. cenocepacia ST32. Its implementation into Bcc infection
surveillance programme is advisable for CF populations with high rate of ST32
infection.
Supported by GAUK 307311; NS10543−3.
114 Comparison of two methods for identiﬁcation of Mycobacterium
abscessus and Mycobacterium chelonae
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Background: Lung infection with Mycobacterium abscessus in patients with cystic
ﬁbrosis (CF) increases morbidity and mortality post lung transplant.Mycobacterium
chelonae is a closely related species, usually considered benign in CF and our
experience suggests there is a low risk of infective complications post transplan-
tation. These species can be difﬁcult to distinguish phenotypically and molecular
characterisation may be complex. We compared two methods to determine the
optimal method for accurate, rapid identiﬁcation of these species.
Materials and Methods: We compared matrix-assisted laser desorption/ionisation
time-of-ﬂight mass spectrometry (MALDI-TOF MS) and the GenoType Mycobac-
terium CM (Hain Lifescience) for the identiﬁcation of 42 M. abscessus and
55 M. chelonae including isolates recovered from the sputa of patients with CF.
All isolates had previously been characterized by rpoB gene sequencing. Three
extraction methods were compared to determine the most reliable preparation
technique for MALDI-TOF-MS.
Results: The Hain test and MALDI-TOF MS correctly identiﬁed 12% and 100% of
42 M. abscessus isolates and 98% and 94% of 55 M. chelonae isolates respectively.
88% of M. abscessus isolates were misidentiﬁed as M. chelonae using the Hain
test.
Conclusion:Misidentiﬁcation ofM. abscessus asM. chelonae in CF lung transplant
recipients can have serious consequences. Sequencing of the rpoB gene is the most
reliable for differentiation of these two species but is only performed in specialist
reference laboratories. Where MALDI-TOF MS instrumentation is available, this
technique may serve as a rapid, reliable and inexpensive way of speciating M. ab-
scessus.
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Introduction/objectives: Prevalence of CF-associated nontuberculous mycobacteria
(NTM) lung disease is steadily rising. We reviewed NTM prevalence in our CF
population, and its association with clinical or immunologic features.
Methods: CF patient records from 2003–2011 including demographic, genetic and
metabolic data and cytokines proﬁles (taken in 2008) were reviewed. NTM sputum
cultures were taken twice per year and at every visit if previously positive.
Results: The prevalence of NTM-positive cultures in clinic patients (age 9mo to
61 yr) increased 3-fold, from 5% (4/79 pts) in 2003 to 14.5% (16/110 pts) in
2011. In 2011 60% (10 pts) had NTM lung disease by deﬁnition; species included:
M. abscessus (40%),M. intracellulare (25%) andM. fortuitum (20%). NTM-positive
culture correlated with CFTR mutation severity (p< 0.01), pancreatic insufﬁciency
(p< 0.005), chronic P. aeruginosa infection (p< 0.05), ABPA (p< 0.005) and
oral steroids (p = 0.055). There was no correlation between NTM positivity and
gender, FEV1, BMI, sweat chloride, CF-related diabetes or Azithromycin use. IL10,
IL12(p40) and IL17a (all pg/ml) were signiﬁcantly lower in NTM-positive compared
to NTM-negative patients: IL10, 0.42±0.24 vs. 0.71±0.98, p< 0.05; IL12(p40),
9.58±6.7 vs. 17.36±15, p< 0.005; and IL17a, 0.73±0.29 vs. 1.44±1.92, p< 0.01.
There was no signiﬁcant difference in TGFb, IFNg, TNFa, IL4, IL5, IL6 or IL8.
Conclusions: Prevalence of NTM disease in our CF cohort is rising and appears
associated with increased CF clinical and genetic severity. The striking correlation
with ABPA as well as an altered interleukin proﬁle suggests an associated immune
dysregulation.
